Recursion Pharmaceuticals Inc. RXRX shares are trending on Friday. Shares of the Utah-based clinical-stage biotechnology company edged 0.24% higher to $4.17 after the bell on Thursday, following a ...

Recursion Pharmaceuticals RXRX, a TechBio company, is expected to beat expectations when it reports third-quarter 2026 results on Nov. 2, 2026. The Zacks Consensus Estimate is pegged at a loss of 24 ...

Recursive Superintelligence, the startup trying to build AI that improves itself, has released its first model. Flint is a free coding model small enough to run on a laptop. Recursive says its own ...

AI's share of AI-model research and development at Anthropic, by month Note: As of August, 0% of AI R+D is fully autonomous. Parts may not add to 100% due to rounding. Note: As of August, 0% of AI R+D ...

For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...

Recursive, an AI startup founded last year, is starting to live up to its name. The company, which is trying to build AI that can improve itself, released its first model, Flint, on Wednesday. Flint ...

You're currently following this author! Click to unsubscribe from email alerts. Google may be approaching a pivotal moment in AI. In a roundtable discussion about the creation of Google's new Gemini 4 ...

The US military has developed new strike plans that include potentially using the so-called “mother of all bombs” to target Iranian energy infrastructure and nuclear sites should President Donald ...